Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid With/Without Drain in Knee Arthroplasty
NCT07174895Completed
- Sponsor
- Idlib University
- Start
- Aug 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in osteoarthritis (OA) (3 arms), sponsored by Idlib University. Primary endpoints: Total Blood Loss at 72 hours and Number of Blood Transfusions at 7 days. Started Aug 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07174895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07174895.